http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-111373-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2638d2ba1c85299f1075e3d2e54985b9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09J11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f27eef432252ad5623e801567ea6590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69784ab40d1084e5bdcbcd3bb7a2595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85afb24fae4f1d88c06957ccd1cf9358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356a23b6a876f14e0b247e118dae029a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc1150910c2ec5c30b5c29293f77ed19
publicationDate 1999-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-111373-A
titleOfInvention Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof
abstract A TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF PHYSOSTIGMINE TO THE SKIN, CONSISTING OF A BACKING IMPERMEABLE TO ACTIVE SUBTANCE, A PRESSURE-SENSITIVE RESERVOIR LAYER CONTAINING 40 TO 90WT. POLYMERIC MATERIAL AND 0.1 TO 20WT.PHYSOSTIGMINE BASE OR ONE OF THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND OF A PROTECTIVE LAYER COVERING THE RESERVOIR LAYER, COMPRISES IN ITS RESERVOIR LAYER ACRYLATE- OR METHACRYLATE-BASED POLYMERIC-BASED MATERIAL AND 0.1 TO 40WT. OF A SOFTENER CONTAINING THE HYDROXYL GROUP WITH AN HLB VALEU BETWEEN 1.1 AND 12.0.
priorityDate 1992-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5983

Total number of triples: 33.